AIXN · As filed with the SEC
AiXin Life International income statement, by quarter
The statement as AiXin Life International presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations and Comprehensive Loss · USD, except per-share amounts
| USD, except per-share amounts | Q4 2025† 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|---|
| Sales revenue | |||||
| Total revenues, net | 327,688† | 301,979 | 460,929 | 398,831 | 703,686† |
| Product | — | 13,735 | 31,337 | — | — |
| Direct Sales | — | — | — | 20,631 | — |
| Pharmacy | 27,858† | 16,933 | 26,441 | 35,966 | 58,463† |
| Hotel | 79,950† | 135,548 | 112,377 | 80,706 | 120,211† |
| Manufacture and Sale | 113,634† | 135,763 | 290,774 | 261,528 | 646,047† |
| Operating costs and expenses | |||||
| Cost of Revenue | 112,665† | 151,482 | 290,675 | 312,999 | 603,724† |
| Hotel operating costs | 301,427† | 255,909 | 254,382 | 270,820 | 261,607† |
| Selling, General and Administrative Expense | 104,523† | 141,724 | 185,796 | 75,700 | 140,958† |
| Selling, General and Administrative Expense | 489,305† | 100,073 | 540,700 | 421,797 | 770,462† |
| Stock-Based Compensation Expense | — | — | — | — | 22,472† |
| Total operating costs and expenses | 1,007,920† | 649,188 | 1,271,553 | 1,081,316 | 1,799,223† |
| Loss from operations | (680,232)† | (347,209) | (810,624) | (682,485) | (1,095,537)† |
| Non-operating income (expenses) | |||||
| Net Interest Income | (9,536)† | (30) | (3,926) | (5,097) | (77,138)† |
| Interest Expense | 2,109† | — | — | — | — |
| Non-Operating Income (Expense) | — | 13,282 | 481,102 | — | — |
| Other expenses | — | (6,499) | (17,829) | (33,305) | — |
| Total non-operating income (expenses), net | 50,780† | 6,753 | 459,347 | (38,402) | (346,234)† |
| Loss before income tax | (629,452)† | (340,456) | (351,277) | (720,887) | (1,441,771)† |
| Income Tax Expense | (663)† | 5 | 228 | 821 | 1† |
| Net loss | (628,789)† | (340,461) | (351,505) | (721,708) | (1,441,772)† |
| Other comprehensive items | |||||
| Foreign currency translation gain (loss) | (115,563)† | (33,997) | (67,632) | (26,693) | 139,577† |
| Comprehensive loss | (744,352)† | (374,458) | (419,137) | (748,401) | (1,302,195)† |
| Earnings Per Share (Basic) | — | (0.01) | (0.01) | (0.03) | — |
| Earnings Per Share (Diluted) | — | (0.01) | (0.01) | (0.03) | — |
| Weighted Average Shares Outstanding | — | 24,999,834 | 24,999,834 | 24,999,834 | — |
| Weighted Average Shares Outstanding, Diluted | — | 24,999,834 | 24,999,834 | 24,999,834 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.